Discover open access scientific publications

Search, annotate, share and cite publications

Publications by G Tonini

Cetuximab and Irinotecan as Third-Line Therapy in Advanced Colorectal Cancer Patients: A Single Centre Phase II Trial

British Journal of Cancer

Cancer Research

Oncology

2006

English

Italian Cross-Sectional Growth Charts for Height, Weight and BMI (6–20 Y)

European Journal of Clinical Nutrition

English

Related publications

Irinotecan Monotherapy as Third-Line or Later Treatment in Advanced Gastric Cancer

English

Phase II Study on the Combination of Irinotecan Plus Cisplatin as a Second-Line Therapy in Patients With Advanced or Recurrent Gastric Cancer

Molecular and Clinical Oncology

Cancer Research

Oncology

2013

English

Phase I Study of TAS-102 and Irinotecan Combination Therapy in Japanese Patients With Advanced Colorectal Cancer

Investigational New Drugs

Oncology

Pharmacology

2015

English

N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy

Clinical Breast Cancer

Cancer Research

Oncology

2016

English

A Trial Protocol of Biweekly TAS-102 and Bevacizumab as Third-Line Chemotherapy for Advanced/Recurrent Colorectal Cancer: A Phase II Multicenter Clinical Trial (The TAS-CC4 Study)

Journal of the Anus, Rectum and Colon

2019

English

Phase II Trial of UFT in Advanced Colorectal and Gastric Cancer

British Journal of Cancer

Cancer Research

Oncology

1990

English

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Journal of IMAB - Annual Proceeding (Scientific Papers)

Dentistry

2011

English

Phase-Ii Study of Dose Attenuated Schedule of Irinotecan, Capecitabine, and Celecoxib in Advanced Colorectal Cancer

Cancer Chemotherapy and Pharmacology

English

Cetuximab Plus Cisplatin, Irinotecan, and Thoracic Radiotherapy as Definitive Treatment for Locally Advanced, Unresectable Esophageal Cancer: A Phase-Ii Study of the SWOG (S0414)

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by G Tonini

Cetuximab and Irinotecan as Third-Line Therapy in Advanced Colorectal Cancer Patients: A Single Centre Phase II Trial

Italian Cross-Sectional Growth Charts for Height, Weight and BMI (6–20 Y)

Related publications

Irinotecan Monotherapy as Third-Line or Later Treatment in Advanced Gastric Cancer

Phase II Study on the Combination of Irinotecan Plus Cisplatin as a Second-Line Therapy in Patients With Advanced or Recurrent Gastric Cancer

Phase I Study of TAS-102 and Irinotecan Combination Therapy in Japanese Patients With Advanced Colorectal Cancer

N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy

A Trial Protocol of Biweekly TAS-102 and Bevacizumab as Third-Line Chemotherapy for Advanced/Recurrent Colorectal Cancer: A Phase II Multicenter Clinical Trial (The TAS-CC4 Study)

Phase II Trial of UFT in Advanced Colorectal and Gastric Cancer

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Phase-Ii Study of Dose Attenuated Schedule of Irinotecan, Capecitabine, and Celecoxib in Advanced Colorectal Cancer

Cetuximab Plus Cisplatin, Irinotecan, and Thoracic Radiotherapy as Definitive Treatment for Locally Advanced, Unresectable Esophageal Cancer: A Phase-Ii Study of the SWOG (S0414)